Articles
The new Fildas-Catena results brochure
Browse the brochure online: The financial results of Fildas-Catena Group continued their growth trend throughout 2023, in line with the ambitious objectives we have set for ourselves. These results reflect...
Read more »
Read more »
Articles
Anca Vlad, Forbes Business Bridges 2024, New York: ”Trust is our core value”
At the second panel of the inaugural Forbes Business Bridges event in New York, experts and leaders from the luxury retail industry gathered to explore how iconic brands are navigating...
Read more »
Read more »
News
The Fildas-Catena Group, awarded at the 2024 Forbes 500 Business Awards Gala
The Fildas-Catena Group, a leader in pharmaceutical distribution and retail in Romania, was awarded at the 2024 Forbes 500 Business Awards Gala for its outstanding performance over the past year...
Read more »
Read more »
Articles
The Fildas-Catena Group, awarded at the Capital Gala Elite Companies 2024 for consolidating its leadership position in the pharmaceutical sector
The Fildas-Catena Group, founded and led by entrepreneur Anca Vlad, received the Award for consolidating its leading status in the Romanian pharmaceutical distribution and retail sector, at the Elite Companies...
Read more »
Read more »
Media Appearances
Ziarul Financiar: “Local entrepreneurs. The Fildas-Catena Group, controlled by Anca Vlad, reached 14 billion lei cumulative business from distribution and pharmacies in 2023”
Article published in the print edition of Ziarul Financiar on May 22, 2024: “The Fildas-Catena Group, the largest player in the pharmaceutical market, created by entrepreneur Anca Vlad three decades...
Read more »
Read more »
Articles
Forbes: 50 most influential women, Edition 2024, 1st place: Anca Vlad, President of the Fildas-Catena Group
“Anca Vlad, Romania’s best-known and most appreciated female entrepreneur, is the founder and president of Fildas-Catena Grup, a leading pharmaceutical distribution and retailer in Romania. A graduate of the Academy...
Read more »
Read more »